IL105943A0 - Steroids with pregnane skeleton,their preparation and pharmaceutical compositions containing them - Google Patents
Steroids with pregnane skeleton,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL105943A0 IL105943A0 IL105943A IL10594393A IL105943A0 IL 105943 A0 IL105943 A0 IL 105943A0 IL 105943 A IL105943 A IL 105943A IL 10594393 A IL10594393 A IL 10594393A IL 105943 A0 IL105943 A0 IL 105943A0
- Authority
- IL
- Israel
- Prior art keywords
- steroids
- preparation
- pharmaceutical compositions
- compositions containing
- pregnane skeleton
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9201910A HU212308B (en) | 1992-06-09 | 1992-06-09 | Process for producing novel pregnane steroids and pharmaceutical compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL105943A0 true IL105943A0 (en) | 1993-10-20 |
Family
ID=10982020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105943A IL105943A0 (en) | 1992-06-09 | 1993-06-08 | Steroids with pregnane skeleton,their preparation and pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5547949A (sv) |
| EP (1) | EP0646126A1 (sv) |
| JP (1) | JPH07507792A (sv) |
| KR (1) | KR950701933A (sv) |
| AU (1) | AU4352393A (sv) |
| CA (1) | CA2136546A1 (sv) |
| CZ (1) | CZ308094A3 (sv) |
| EE (1) | EE9400071A (sv) |
| FI (1) | FI945781A (sv) |
| HR (1) | HRP930956A2 (sv) |
| HU (1) | HU212308B (sv) |
| IL (1) | IL105943A0 (sv) |
| NO (1) | NO944749L (sv) |
| RU (1) | RU94046369A (sv) |
| SI (1) | SI9300311A (sv) |
| WO (1) | WO1993025570A1 (sv) |
| ZA (1) | ZA934036B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999061055A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| US7081470B2 (en) * | 2001-01-31 | 2006-07-25 | H. Lundbeck A/S | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| US20040127502A1 (en) * | 2001-01-31 | 2004-07-01 | Synaptic Pharmaceutical Corporation | Use of GAL3 antagonist for treatment of depression |
| MY141867A (en) * | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| WO2006116718A2 (en) | 2005-04-28 | 2006-11-02 | Proteus Biomedical, Inc. | Pharma-informatics system |
| WO2007035716A2 (en) | 2005-09-16 | 2007-03-29 | Raptor Pharmaceutical Inc. | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
| NL2000323C2 (nl) * | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
| ES2744879T3 (es) | 2008-05-28 | 2020-02-26 | Reveragen Biopharma Inc | Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| EA024559B1 (ru) | 2009-05-06 | 2016-09-30 | Лаборэтори Скин Кэа, Инк. | Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки |
| WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
| EP0263213B1 (en) * | 1986-10-09 | 1995-09-06 | The Upjohn Company | C20 Through C26 amino steroids |
| FR2644787B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| FR2644789B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| CA2071000A1 (en) * | 1990-01-26 | 1991-07-27 | John M. Mccall | 5-oxygenated-2,4,6-triaminopyrimidines |
-
1992
- 1992-06-09 HU HU9201910A patent/HU212308B/hu not_active IP Right Cessation
-
1993
- 1993-06-08 ZA ZA934036A patent/ZA934036B/xx unknown
- 1993-06-08 EP EP93913455A patent/EP0646126A1/en not_active Withdrawn
- 1993-06-08 CZ CZ943080A patent/CZ308094A3/cs unknown
- 1993-06-08 US US08/351,448 patent/US5547949A/en not_active Expired - Fee Related
- 1993-06-08 CA CA002136546A patent/CA2136546A1/en not_active Abandoned
- 1993-06-08 JP JP6501316A patent/JPH07507792A/ja active Pending
- 1993-06-08 IL IL105943A patent/IL105943A0/xx unknown
- 1993-06-08 KR KR1019940704496A patent/KR950701933A/ko not_active Application Discontinuation
- 1993-06-08 AU AU43523/93A patent/AU4352393A/en not_active Abandoned
- 1993-06-08 WO PCT/HU1993/000035 patent/WO1993025570A1/en not_active Application Discontinuation
- 1993-06-08 HR HRP930956AA patent/HRP930956A2/hr not_active Application Discontinuation
- 1993-06-09 SI SI9300311A patent/SI9300311A/sl unknown
-
1994
- 1994-06-29 EE EE9400071A patent/EE9400071A/xx unknown
- 1994-12-06 RU RU94046369/04A patent/RU94046369A/ru unknown
- 1994-12-08 NO NO944749A patent/NO944749L/no unknown
- 1994-12-08 FI FI945781A patent/FI945781A/sv not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO944749D0 (no) | 1994-12-08 |
| FI945781A0 (sv) | 1994-12-08 |
| EP0646126A1 (en) | 1995-04-05 |
| HU9201910D0 (en) | 1992-09-28 |
| RU94046369A (ru) | 1996-09-27 |
| EE9400071A (et) | 1995-12-15 |
| AU4352393A (en) | 1994-01-04 |
| JPH07507792A (ja) | 1995-08-31 |
| CA2136546A1 (en) | 1993-12-23 |
| NO944749L (no) | 1995-02-08 |
| CZ308094A3 (en) | 1995-11-15 |
| HU212308B (en) | 1996-05-28 |
| HRP930956A2 (hr) | 1995-02-28 |
| SI9300311A (sl) | 1993-12-31 |
| US5547949A (en) | 1996-08-20 |
| WO1993025570A1 (en) | 1993-12-23 |
| KR950701933A (ko) | 1995-05-17 |
| HUT64562A (en) | 1994-01-28 |
| FI945781A (sv) | 1994-12-08 |
| ZA934036B (en) | 1994-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100136A3 (en) | 11-or 17-substituted estratriols, process for their preparation, use of them and pharmaceutical compositions containing the same | |
| HU9401353D0 (en) | New lupane derivatives, preparation thereof and pharmaceutical compositions containing them | |
| IL109836A0 (en) | Spiro-substituted azacycles, pharmaceutical compositions containing them and their preparation | |
| IL104915A0 (en) | Pharmaceutical composition containing estrogen,progestin and antiprogestin and kits containing the same | |
| NZ219776A (en) | 11-substituted steroid 17, 2'-furan derivatives and pharmaceutical compositions | |
| IL108218A0 (en) | Benzanilide derivatives, their preparation and pharmaceutical compositions containing them | |
| GB8830380D0 (en) | New derivatives of 17beta-oh 19-nor steroids substituted in the 17alpha position,their preparation,their use as medicaments and pharmaceutical compositions | |
| IL105943A0 (en) | Steroids with pregnane skeleton,their preparation and pharmaceutical compositions containing them | |
| PH19849A (en) | Steroids and their pharmaceutical composition | |
| AU8256091A (en) | Corticoid-17-alkylcarbonates substituted in the 17-position process for their preparation and pharmaceuticals containing them | |
| IL81164A0 (en) | Aminoglycosides of steroids,their preparation and pharmaceutical compositions containing them | |
| IL75569A (en) | 7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them | |
| IL96366A0 (en) | Steroids,their manufacture and pharmaceutical compositions containing them | |
| IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them | |
| AU6724494A (en) | Novel lupane derivatives, their preparation and pharmaceutical compositions containing same | |
| AU6787994A (en) | Novel lupane derivatives, their preparation and pharmaceutical compositions containing same | |
| IL93478A0 (en) | Steroid diols,pharmaceutical compositions containing them and their preparation | |
| IL105774A0 (en) | Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL107994A0 (en) | Steroids process for their preparation and pharmaceutical compositions containing them | |
| IL105370A0 (en) | Propenoyl-imidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL136148A0 (en) | NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| IL104306A0 (en) | Nucleosides,their preparation and pharmaceutical compositions containing them | |
| NZ216325A (en) | #w# 4,9 -11b-substituted steroids and pharmaceutical compositions | |
| IL104525A0 (en) | 4-cinnolinyl-and 4-naphthyridinyl-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| IL116504A0 (en) | 14, 17-C2-bridged steroids and pharmaceutical compositions containing the same |